Premium
P2–402: Double–blind, placebo–controlled study of three different dosages of cerebrolysin in patients with mild to moderate Alzheimer's disease
Author(s) -
Alvarez Anton,
Laredo Marta,
Varela Miguel,
Cacabelos Ramon,
Sanpedro Carolina,
Aleixandre Manuel,
Linares Carlos,
Moessler Herbert
Publication year - 2006
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2006.05.1243
Subject(s) - cerebrolysin , placebo , dose , medicine , clinical global impression , clinical trial , randomized controlled trial , alzheimer's disease , psychology , disease , pathology , alternative medicine